A new molecule could significantly reduce the cycles of airway inflammation and infection that eventually result in fatal destruction of the lungs in people with cystic fibrosis.
A new study led by a team from the Research Institute of the McGill University Health Centre and Cystic Fibrosis Canada supports the benefits of newborn screening programs for cystic fibrosis.
A new study led by a team from the Research Institute of the McGill University Health Centre and Cystic Fibrosis Canada reinforces the benefits of newborn screening for cystic fibrosis patients.
Josiah Ferrell, a 25-year-old cystic fibrosis patient, received a dual lung and liver transplant and is the first patient to undergo the procedure in North Texas.
Recent data suggests that the sticky mucus found in cystic fibrosis patients is more viscous because the thin layer coating the airways is more acidic.
The antimicrobial agent Mul-1867 for the treatment of bacterial lung infections in cystic fibrosis patients has been granted Orphan Drug Designation by the FDA.
Raptor Pharmaceutical Corp has announced its first commercial sale of Quinsair, a levofloxacin inhalation solution for cystic fibrosis treatment, in Germany and Denmark.
RT consulted with some leading device manufacturers about today’s airway clearance products and the industry and technology trends in the next few years.
Ivacaftor (Kalydeco) treatment improves airway flexibility and capacity in patients with cystic fibrosis, according to a new study.
Symptoms of Scedosporium apiospermum colonization in patients with cystic fibrosis may resemble symptoms of plastic bronchitis, according to research.
Nivalis Therapeutics has reached the halfway point in dosing of the 135 patient Phase 2 clinical trial evaluating N91115, an investigational drug and first-in-class stabilizer of the CFTR protein.
The Cystic Fibrosis Foundation has issued new clinical practice guidelines for the treatment of preschoolers suffering from CF. The guidelines were published in the journal Pediatrics.
The Indian Patent Office has refused a patent to Vertex Pharmaceuticals for its cystic fibrosis drug Orkambi.
An ongoing study will explore tailored medical care and treatment for patients with cystic fibrosis.
Volatile compounds released by bacterial pathogen Pseudomonas aeruginosa can trigger the growth of fungal pathogen Aspergillus fumigatus, often found in cystic fibrosis patients.
The FDA has granted Qualified Infectious Disease Product designation to MP-376, Raptor Pharmaceutical’s inhaled levofloxacin to treat pulmonary infections.
New data reveals that viral infections in cystic fibrosis patients are linked to pulmonary exacerbations.
A new review by the University of Liverpool examines the recent research progress into how P. aeruginosa adapts and evolves in chronically infected cystic fibrosis patients.
RespirTech has introduced a new remote monitoring system that wirelessly transmits spirometry and HFCC airway clearance data for treatment of cystic fibrosis patients.
Hepatopulmonary syndrome may be under diagnosed in at-risk patients with cystic fibrosis, according to a study.